A Man on Fire Fueled by a Mission to Find a Drug for Every Disease

David Fajgenbaum has become a "man on fire," determined to repurpose as many generic drugs as possible for diseases without approved treatments. Fajgenbaum, whose efforts have been recognized by former President Bill Clinton, spoke with In Vivo about his own patient journey with a disease with no approved treatment and about the Every Cure Foundation, a nonprofit he cofounded to fulfill his ambitions.


By David Wild

David Fajgenbaum is on a mission to repurpose drugs for the 9,000 diseases with no approved treatments. Fajgenbaum's journey started as a patient with idiopathic multicentric Castleman disease, an illness that he nearly succumbed to five times and for which he found a treatment. In September 2022, Fajgenbaum cofounded the Every Cure Foundation, a nonprofit organization that identifies and tests generic medicines for novel indications.

Related resources

InVivo-Outlook-2023_resource-card-thumbnail
DEC 01, 2022
Report
Commercial

In Vivo Outlook 2023

Outlook 2023 includes exclusive interviews and features on topics that reach across the life sciences.

2023 Rising Leaders resource-card-thumbnail
MAY 10, 2023
Infographic
Commercial

In Vivo Rising Leaders 2023

The 4th annual In Vivo’s Rising Leaders includes entrepreneurs & innovators from across the world who represent the next wave of creativity in healthcare.

a group of pills and capsules
JUL 01, 2023
Article
Commercial

Floodgates Open for US Humira Biosimilars; Key TB Drug Can Move in India

Generics Bulletin previews the most notable and anticipated events for July 2023